These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
793 related articles for article (PubMed ID: 32569766)
21. [Gut-liver axis: How intestinal bacteria affect the liver]. Konturek PC; Harsch IA; Konturek K; Schink M; Zopf Y MMW Fortschr Med; 2018 Nov; 160(Suppl 5):11-15. PubMed ID: 30367438 [TBL] [Abstract][Full Text] [Related]
22. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933 [TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota in Intestinal and Liver Disease. Jones RM; Neish AS Annu Rev Pathol; 2021 Jan; 16():251-275. PubMed ID: 33234022 [TBL] [Abstract][Full Text] [Related]
24. The First Line of Defense: The Effects of Alcohol on Post-Burn Intestinal Barrier, Immune Cells, and Microbiome. Hammer AM; Morris NL; Earley ZM; Choudhry MA Alcohol Res; 2015; 37(2):209-22. PubMed ID: 26695746 [TBL] [Abstract][Full Text] [Related]
25. Rice Bran Phenolic Extract Protects against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Barrier Dysfunction, and Liver Inflammation Mediated by the Endotoxin-TLR4-NF-κB Pathway. Xiao J; Zhang R; Wu Y; Wu C; Jia X; Dong L; Liu L; Chen Y; Bai Y; Zhang M J Agric Food Chem; 2020 Feb; 68(5):1237-1247. PubMed ID: 31722525 [TBL] [Abstract][Full Text] [Related]
26. Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis. Maslennikov R; Poluektova E; Zolnikova O; Sedova A; Kurbatova A; Shulpekova Y; Dzhakhaya N; Kardasheva S; Nadinskaia M; Bueverova E; Nechaev V; Karchevskaya A; Ivashkin V Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003692 [TBL] [Abstract][Full Text] [Related]
27. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531 [TBL] [Abstract][Full Text] [Related]
28. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. Utzeri E; Usai P World J Gastroenterol; 2017 Jun; 23(22):3954-3963. PubMed ID: 28652650 [TBL] [Abstract][Full Text] [Related]
29. Role of γδT cells in liver diseases and its relationship with intestinal microbiota. Zhou QH; Wu FT; Pang LT; Zhang TB; Chen Z World J Gastroenterol; 2020 May; 26(20):2559-2569. PubMed ID: 32523311 [TBL] [Abstract][Full Text] [Related]
31. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Plaza-Díaz J; Solís-Urra P; Rodríguez-Rodríguez F; Olivares-Arancibia J; Navarro-Oliveros M; Abadía-Molina F; Álvarez-Mercado AI Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171747 [TBL] [Abstract][Full Text] [Related]
32. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827 [TBL] [Abstract][Full Text] [Related]
33. Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice. Isaacs-Ten A; Echeandia M; Moreno-Gonzalez M; Brion A; Goldson A; Philo M; Patterson AM; Parker A; Galduroz M; Baker D; Rushbrook SM; Hildebrand F; Beraza N Hepatology; 2020 Dec; 72(6):2090-2108. PubMed ID: 32168395 [TBL] [Abstract][Full Text] [Related]
34. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. Graziani C; Talocco C; De Sire R; Petito V; Lopetuso LR; Gervasoni J; Persichilli S; Franceschi F; Ojetti V; Gasbarrini A; Scaldaferri F Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):795-810. PubMed ID: 30720188 [TBL] [Abstract][Full Text] [Related]
35. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836 [TBL] [Abstract][Full Text] [Related]
36. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676 [TBL] [Abstract][Full Text] [Related]
37. [The gut microbiome is important in chronic liver disease]. Christensen E Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372 [TBL] [Abstract][Full Text] [Related]
38. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. Rizzetto L; Fava F; Tuohy KM; Selmi C J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127 [TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. Hu H; Lin A; Kong M; Yao X; Yin M; Xia H; Ma J; Liu H J Gastroenterol; 2020 Feb; 55(2):142-158. PubMed ID: 31845054 [TBL] [Abstract][Full Text] [Related]
40. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Arab JP; Martin-Mateos RM; Shah VH Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]